SCR'21 - Update on malignant mesothelioma: Pathogenesis, diagnostic evaluation, staging and therapeutic concepts

Do30Sep7:00 nachm.8:00 nachm.SCR'21 - Update on malignant mesothelioma: Pathogenesis, diagnostic evaluation, staging and therapeutic concepts1 Credit

Veranstaltungsdetails

SCR’21 Online Edition Webinar 5
Joint plenary session SGR-SSR/SGNM-SSMN

Update on malignant mesothelioma: Pathogenesis, diagnostic evaluation, staging and therapeutic concepts

Moderators: J. Prior, Lausanne/CH; B. Halpern, Münsterlingen/CH

Update on malignant mesothelioma: Pathogenesis and diagnostic evaluation
Speaker: L. R. Chirieac, Harvard/US
Learning objectives:
– To present recently described genomic and pathogenetic alterations in mesothelioma
– To describe current immunohistochemical antibodies with diagnostic importance in mesothelioma

Diagnostic evaluation and staging – Significant imaging concepts
Speaker: R. R. Gill, Harvard/US
Learning objectives:
– To review the role of multimodality imaging in evaluation of Malignant Pleural Mesothelioma
– To illustrate how quantitative imaging techniques play a role in staging and management of Mesothelioma

New European treatment guidelines for MPM
Speaker: I. Opitz, Zurich/CH
Learning objectives:
– To learn the recommendations from recent European Guidelines about MPM treatment
– To learn the recommendations from recent European Guidelines about Diagnosis of MpM

This session is accredited with 1 SGR-SSR CME credit (Category 1), 1 SGNM-SSMN CME credit (Formation continue essentielle spécifique/Fachspezifische Kernfortbildung) and 1 SVMTR-ASTRM log-point.

Zeit

September 30, 2021 7:00 nachm. - 8:00 nachm.(GMT+00:00)

Ort

online only

Other Events